Partial Thromboplastin Time During the First 24 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin (UFH)
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the incidence of abnormal partial thromboplastin time in
patients receiving unfractionated heparin (UFH) 5000 U 2 times a day versus 3 times a day.
The basic hypothesis of this study is that patients receiving UFH 5000 U subcutaneously 3
times a day will have a higher proportion of elevated partial thromboplastin time than
patients receiving UFH 5000 U subcutaneously twice a day.